AIP
DXCM icon

Ahrens Investment Partners’s DexCom DXCM Stock Holding History

Ahrens Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.56K Buy
+22
New +$2.46K ﹤0.01% 855

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ahrens Investment Partners's DXCM Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in DexCom (DXCM) in Q1 2023: 22 shares worth $2.56K. The stake represents ﹤0.01% of the portfolio and ranks #855 among its holdings.

904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Ahrens Investment Partners held 22 shares of DexCom worth $2.56K as of Q1 2023.
  • DexCom was a new Ahrens Investment Partners position in Q1 2023.
  • DexCom made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #855 holding.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.